Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acadia Healthcare Company, Inc. - Common Stock (NQ:ACHC)

22.35 +0.17 (+0.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Acadia Healthcare Company, Inc. - Common Stock

< Previous 1 2 3 4 Next >
1 Healthcare Stock Worth Your Attention and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
3 of Wall Street’s Favorite Stocks in the Doghouse
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Hospital Chains Stocks Q4 Teardown: Acadia Healthcare (NASDAQ:ACHC) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how hospital chains stocks fared in Q4, starting with Acadia... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Market Whales and Their Recent Bets on ACHC Options
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Acadia Healthcare Co Stock
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Where Acadia Healthcare Co Stands With Analysts
Via Benzinga
3 Reasons to Avoid ACHC and 1 Stock to Buy Instead
What a brutal six months it’s been for Acadia Healthcare. The stock has dropped 56.9% and now trades at $24.75, rattling many shareholders. This was partly due to its softer quarterly results and may... 
Via StockStory
Is Acadia Healthcare Co Gaining or Losing Market Support?
Via Benzinga
Hospital Chains Stocks Q4 In Review: Tenet Healthcare (NYSE:THC) Vs Peers
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how hospital chains stocks fared in Q4, starting with Tenet... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
5 Stock Picks Last Month From Wall Street's Most Accurate Analysts
Via Benzinga
A Glimpse Into The Expert Outlook On Acadia Healthcare Co Through 7 Analysts
Via Benzinga
Decoding 5 Analyst Evaluations For Acadia Healthcare Co
Via Benzinga
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week
Via Benzinga
3 Value Stocks in Hot Water
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Spotting Winners: HCA Healthcare (NYSE:HCA) And Hospital Chains Stocks In Q4
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at HCA Healthcare (NYSE:HCA) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Forecasting The Future: 8 Analyst Projections For Acadia Healthcare Co
Via Benzinga
Hospital Chains Stocks Q4 Earnings: Universal Health Services (NYSE:UHS) Firing on All Cylinders
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the hospital chains industry, including Universal Health Services (NYSE:UHS) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Hewlett Packard Enterprise Issues Weak Forecast, Joins Clarus, Samsara And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Acadia Healthcare (ACHC) Stock Is Nosediving
Shares of behavioral health company Acadia Healthcare (NASDAQ:ACHC) fell 24.1% in the afternoon session after the company reported weak fourth quarter results: Its revenue guidance for next quarter... 
Via StockStory
Nasdaq, S&P 500 Head for Worst Weekly Losses Since September
Stocks are higher midday, getting a much-needed lift from this morning's inflation data that came in line with estimates. 
Via Talk Markets
Topics Economy Stocks Stocks / Equities
Exposures Interest Rates US Equities
Get insights into the top gainers and losers of Friday's pre-market session.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Acadia Healthcare (NASDAQ:ACHC) Misses Q4 Revenue Estimates, Stock Drops 13.9%
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 4.2% year on year to $774.2 million. Next quarter’s revenue guidance of... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings To Watch: Acadia Healthcare (ACHC) Reports Q4 Results Tomorrow
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) will be reporting results tomorrow after market close. Here’s what investors should know. 
Via StockStory
3 Reasons ACHC is Risky and 1 Stock to Buy Instead
Shareholders of Acadia Healthcare would probably like to forget the past six months even happened. The stock dropped 43.2% and now trades at $41.25. This was partly due to its softer quarterly results... 
Via StockStory
Psychiatric Hospital Operator Acadia Healthcare Earns Upgrade Amid Expected Recovery In 2025
KeyBanc anticipates healthcare services stocks will thrive in 2025, with growth driven by higher patient volumes and improving Medicare Advantage policies. 
Via Benzinga
This Robinhood Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Rigetti Computing, VEON And Intuitive Machines Are Among Top Mid-Cap Gainers Last Week (Dec 30-Jan 3): Are The Others In Your Portfolio?
8 top-performing mid-cap stocks last week: RGTI, VEON, NEXT, GDS, ACHC, LUNR, BBAR, TGS. Did you have them in your portfolio? 
Via Benzinga
Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"
Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks. 
Via MarketBeat
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.